These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6322448)

  • 1. Inactivation of non-A, non-B virus infectivity by a beta propiolactone/ultraviolet irradiation treatment and Aerosil adsorption procedure used for preparation of a stabilized human serum.
    Prince AM; Stephan W; Brotman B
    Vox Sang; 1984; 46(2):80-5. PubMed ID: 6322448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-propiolactone for the inactivation of non-A/non-B type 1 hepatitis virus capable of inducing cytoplasmic tubular ultrastructures in chimpanzees.
    Yoshizawa H; Itoh Y; Iwakiri S; Kitajima K; Noguchi Y; Tachibana K; Nakamura T; Miyakawa Y; Mayumi M
    Vox Sang; 1984; 46(2):86-91. PubMed ID: 6422638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
    Prince AM; Stephan W; Kotitschke R; Brotman B
    Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone].
    Dichtelmüller H; Stephan W; Prince AM; Brotman B
    Beitr Infusionsther; 1988; 21():202-4. PubMed ID: 2462976
    [No Abstract]   [Full Text] [Related]  

  • 5. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation.
    Prince AM; Stephan W; Dichtelmüller H; Brotman B; Huima T
    J Med Virol; 1985 Jun; 16(2):119-25. PubMed ID: 3925077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the Hutchinson strain of hepatitis non-A, non-B virus in intravenous immunoglobulin by beta-propiolactone.
    Stephan W; Dichtelmüller H; Prince AM; Brotman B; Huima T
    J Med Virol; 1988 Nov; 26(3):227-32. PubMed ID: 3144576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.
    Prince AM; Stephan W; Brotman B; van den Ende MC
    Thromb Haemost; 1980 Dec; 44(3):138-42. PubMed ID: 7466740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined treatment of serum containing hepatitis B virus with beta-propiolactone and ultraviolet irradiation.
    Stephan W; Berthold H; Prince AM
    Vox Sang; 1981 Sep; 41(3):134-8. PubMed ID: 7331286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-propiolactone/ultraviolet irradiation: a review of its effectiveness for inactivation of viruses in blood derivatives.
    Prince AM; Stephan W; Brotman B
    Rev Infect Dis; 1983; 5(1):92-107. PubMed ID: 6828813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
    Stephan W
    Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
    Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
    Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of an agent of human non-A, non-B hepatitis by formalin.
    Tabor E; Gerety RJ
    J Infect Dis; 1980 Nov; 142(5):767-70. PubMed ID: 6780630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.
    Prince AM; Horowitz B; Brotman B
    Lancet; 1986 Mar; 1(8483):706-10. PubMed ID: 2870224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the hepatitis safety of a beta-propiolactone/ultraviolet treated factor IX concentrate (PPSB).
    Heinrich D; Kotitschke R; Berthold H
    Thromb Res; 1982 Oct; 28(1):75-83. PubMed ID: 7157232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROPIOLACTONE PLUS ULTRAVIOLET-TREATED PLASMA WITHOUT HEPATITIS. SIX YEARS' EXPERIENCE.
    LOGRIPPO GA; WOLFRAM BR; BRUSH BE
    Arch Surg; 1964 Apr; 88():721-4. PubMed ID: 14107028
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of hepatitis A virus added to pooled human plasma by beta-propiolactone treatment and ultraviolet irradiation.
    Frösner GG; Stephan W; Dichtelmüller H
    Eur J Clin Microbiol; 1983 Aug; 2(4):355-7. PubMed ID: 6313360
    [No Abstract]   [Full Text] [Related]  

  • 17. Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis.
    Tabor E; Peterson DA; April M; Seeff LB; Gerety RJ
    J Med Virol; 1980; 5(2):103-8. PubMed ID: 6768842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.
    Feinstone SM; Mihalik KB; Kamimura T; Alter HJ; London WT; Purcell RH
    Infect Immun; 1983 Aug; 41(2):816-21. PubMed ID: 6409813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TEN YEAR CLINICAL STUDY OF PLASMA TREATED WITH BETAPRONE AND COMBINED BETAPRONE PLUS ULTRAVIOLET IRRADIATION. COMPARISON WITH PRESENT METHODS OF TREATMENT.
    LOGRIPPO GA
    Pac Med Surg; 1964; 72():298-302. PubMed ID: 14208310
    [No Abstract]   [Full Text] [Related]  

  • 20. HUMAN PLASMA TREATED WITH ULTRAVIOLET AND PROPIOLACTONE. SIX-YEAR CLINICAL EVALUATION.
    LOGRIPPO GA; WOLFRAM BR; RUPE CE
    JAMA; 1964 Mar; 187():722-6. PubMed ID: 14094292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.